المؤلفون: Cutland CL; Wits African Leadership in Vaccinology Expertise (Wits-Alive), School of Pathology, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science/ National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Science, Johannesburg, South Africa. Electronic address: clare.cutland@wits.ac.za., Sawry S; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: SSawry@wrhi.ac.za., Fairlie L; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: LFairlie@wrhi.ac.za., Barnabas S; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa. Electronic address: barnabas@sun.ac.za., Frajzyngier V; Pfizer, Inc., New York City, NY, USA. Electronic address: vfrajzyngier@gmail.com., Roux JL; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: JLeRoux@wrhi.ac.za., Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science/ National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Science, Johannesburg, South Africa. Electronic address: alane.izu@wits-vida.org., Kekane-Mochwari KE; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: mochwari@gmail.com., Vika C; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: carolinev@nicd.ac.za., De Jager J; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa. Electronic address: jeannes@sun.ac.za., Munson S; Pfizer Vaccines Clinical Research & Development, Pfizer, Inc, Pearl River, New York, USA. Electronic address: Samantha.Munson@pfizer.com., Jongihlati B; Pfizer Vaccines Clinical Research & Development, Pfizer, Inc, Pearl River, New York, USA. Electronic address: Babalwa.Jongihlati@pfizer.com., Stark JH; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, 1 Portland St, Cambridge, MA, USA. Electronic address: james.h.stark@pfizer.com., Absalon J; Pfizer Vaccines Clinical Research & Development, Pfizer, Inc, Pearl River, New York, USA. Electronic address: judith.absalon@gmail.com.

المصدر: Vaccine [Vaccine] 2024 Feb 27; Vol. 42 (6), pp. 1352-1362. Date of Electronic Publication: 2024 Feb 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes, Gestational* , Maternal Death* , Vaccines*/adverse effects, Female ; Humans ; Infant, Newborn ; Pregnancy ; Retrospective Studies ; South Africa/epidemiology ; Stillbirth/epidemiology